Biogen valuation

BIIB · NASDAQ · USD

Compare Biogen
$250.79Change from previous close: −0.34%Absolute change: −$0.86

Close · November 17, 2026

Valuation

The P/E ratio is 107.2. The average price target of 32 analysts is $268.26.

Data as of November 18, 2026

Biogen compared with similar companies

Biogen's P/E (trailing 12 months): 107.2, +155% against the median of a group of 10 similar companies (42.1).

Biogen's metrics compared with similar companies
MetricBiogenMedian25th–75th percentileBand
P/E (trailing 12 months)107.242.120.8 – 49.4High
Forward P/E15.418.115.8 – 22.0Low
EV/EBITDA13.213.911.8 – 17.5Middle
Price/book1.966.652.27 – 14.2Low
Price/sales3.605.292.55 – 6.83Middle
Gross margin75.8%73.7%71.6% – 75.5%High
Operating margin23.5%32.4%25.0% – 35.9%Low
Net margin3.4%14.4%5.0% – 17.3%Low
ROE1.9%15.1%4.6% – 38.0%Low
Debt/equity0.410.950.45 – 1.74Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Biogen: valuation over time

On the latest fiscal year's earnings (2025), Biogen's P/E today is 28.5, above the median of its last 10 fiscal years (15.3; between 9.44 and 32.5 from 2016 to 2025). Relative to earnings, the stock costs more than it used to.

Biogen P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/E
2025$175.99$8.7920.0
2024$152.92$11.1813.7
2023$258.77$7.9732.5
2022$276.92$20.8713.3
2021$239.92$10.4023.1
2020$244.86$24.809.87
2019$296.73$31.429.44
2018$300.92$21.5813.9
2017$318.57$11.9226.7
2016$283.58$16.9316.8

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$37.07B
Enterprise value
$43.7B
PEG
3.43
EV/revenue
4.24

Profitability and growth

ROA
4.9%
ROIC
7.4%
Revenue growth (year over year)
10.6%

Financial health

Total cash
$1.3B
Total debt
$7.8B
Current ratio
1.95
Quick ratio
0.95
Altman Z-Score
2.89
Piotroski F-Score
5.00

Dividends

Payout ratio
0.0%

Analysts and estimates

Average price target
$268.26
Median price target
$271.00
High price target
$350.00
Low price target
$175.00
Analysts with a price target
32
Consensus
Buy
Forward EPS
$16.26
EPS estimate, current year
$12.54

Shares and trading

Beta
0.09
Average volume
1.08M
Shares outstanding
147.82M
Float
147.29M
Institutional ownership
100.4%
Insider ownership
0.2%
Short interest (% of float)
4.1%
Short ratio (days)
4.05